Podimetrics, an organization that helps sufferers with diabetes forestall severe issues, is teaming up with HealthMed, an worker well being and wellness platform.
HealthMed goals to combine Podimetrics’ SmartMat expertise into its portfolio of advantages meant for big employers, hospitals and municipalities. The corporate additionally offers worker wellness and psychological well being applications.
Podimetrics’ SmartMat measures the foot temperature of high-risk sufferers and scans for early indicators of irritation that would result in wounds, amputations and diabetic foot ulcers.
“Our partnership with HealthMed is a robust collaboration, and we’re excited to work collectively to help people with advanced diabetes who’re on the biggest threat for severe issues,” Dr. Jon Bloom, CEO of Podimetrics, stated in a press release.
“We share a typical mission to deal with prevention and enhance well being outcomes. This collaboration is aimed toward reaching that purpose collectively.”
Tracy Webster, founding father of HealthMed, stated the partnership with Podimetrics and its modern resolution for managing sophisticated diabetes will profit self-insured employers and enhance the continuum of care.
“We stay up for the optimistic impression we are able to make on well being outcomes and the general price of care,” Webster stated in a press release.
THE LARGER TREND
In March, Podimetrics partnered with profit administration group Alivi Well being, which integrated SmartMat expertise into its portfolio of specialty advantages to bolster its podiatry advantages for well being plans and payers.
In 2024, Podimetrics sued Eire-based Bluedrop Medical for patent infringement. Bluedrop has a tool that enables an individual with diabetes to scan their ft for potential situations of foot ulcers.
Based on the compliant, Bluedrop allegedly “straight and/or via subsidiaries, workers, intermediaries or commerce names” dedicated acts of infringement by “importing, providing to promote and promoting an instrumentality that infringes [Podimetrics’] Patents-in-Go well with.” The case was dismissed after Podmetrics withdrew its declare.
In 2022, Podimetrics scored $45 million in a Sequence C financing spherical. The capital was used to broaden Podimetrics’ product improvement and analysis groups in addition to enhance the variety of providers offered by its nurse help groups.
In 2019, Podimetrics raised $13.4 million in Sequence B funding. Rock Well being, Norwich Ventures and Scientific Well being Growth participated within the spherical.
Different corporations within the diabetes area embrace Dexcom, which in 2024 made a $75 million strategic funding in health-tracking ring maker Oura and established a strategic partnership to allow two-way information circulate between Dexcom’s steady glucose monitor (CGM) and the Oura Ring. Dexcom’s $75 million funding introduced Oura’s valuation to greater than $5 billion.
Diabetes and insulin administration software program firm Glytec and pharmaceutical agency Roche joined forces final 12 months to permit using Glytec’s software program in reference to Roche’s point-of-care smart-device hospital blood glucose system cobas pulse within the U.S. and world markets.
Based on Roche, cobas pulse’s strip structure offers lab-like outcomes and lowers the necessity to repeat assessments. The system can be utilized on all affected person populations, together with neonates and intensive care sufferers.
